Skip to content
Recall Observatory FDA recall evidence

Drug product

Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: Alvogen, Inc. Pine Brook, NJ 07058 USA, NDC 47781-355-03

D-0649-2021

February 26, 2021

Class II

Product summary

Firm
Alvogen, Inc
Event
Event 87372
Status
Terminated
Classification
Class II
Quantity
9,696 cartons
Official record key
drug-enforcement:D-0649-2021

Official wording

Reason: Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)

Code information: Lot #: 36924, Exp 6/2021

Distribution pattern: USA nationwide.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent